Voloridge Investment Management’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-88,995
Closed -$1.36M 1656
2022
Q2
$1.36M Buy
+88,995
New +$1.32M 0.01% 1119
2022
Q1
Sell
-119,583
Closed -$3.49M 1764
2021
Q4
$3.49M Sell
119,583
-36,760
-24% -$1.05M 0.02% 854
2021
Q3
$3.37M Buy
156,343
+45,992
+42% +$1.11M 0.02% 842
2021
Q2
$2.83M Sell
110,351
-20,371
-16% -$435K 0.02% 859
2021
Q1
$2.38M Buy
+130,722
New +$2.17M 0.02% 762

Other funds holding CDMO

Voloridge Investment Management's CDMO Position: Q3 2022 in Review

Voloridge Investment Management sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q3 2022, closing a stake of 88,995 shares — an estimated $1.36M sold.

Voloridge Investment Management first reported a position in CDMO in Q1 2021 and held it in 5 quarters. The position peaked at $3.49M in Q4 2021. 184 funds tracked by Wall St. Rank hold CDMO as of Q3 2022.

  • Voloridge Investment Management reported no remaining Avid Bioservices, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Voloridge Investment Management sold 88,995 Avid Bioservices, Inc. Common Stock shares in Q3 2022, an estimated $1.36M.
  • Voloridge Investment Management first reported a position in Avid Bioservices, Inc. Common Stock in Q1 2021 and held it in 5 quarters.
  • Voloridge Investment Management's Avid Bioservices, Inc. Common Stock position peaked at $3.49M in Q4 2021.
  • 184 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q3 2022.

Based on Voloridge Investment Management's 13F filing for Q3 2022, filed 14 Nov 2022.